semaglutide mash approval Novo Nordisk leads therapeutic race The FDA has approved Wegovy

Retatrutide Dosing: What You Need to Know Before Taking It Retatrutide is an investigational triple agonist medication generating significant interest for obesity and type 2 diabetes management

Myostatin inhibitors like apitegromab show early promise for preserving lean mass during GLP-1-assisted weight loss, but havent yet proven they preserve functional strength

Guest J, Bilgin A, Hokin B, et al

Studies without original data or that were not available in English were excluded, as were studies in women without GDM at study entry, women who did not receive metformin during pregnancy and women examined in the preconception or postpartum periods